Insulin Sensitizers: Biguanides
Insulin Sensitizers: Biguanides
Main Mechanism:
Biguanides, primarily represented by metformin, are a class of oral antidiabetic agents that enhance insulin sensitivity and reduce hepatic glucose production.
Their mechanism of action involves several key processes: first, biguanides decrease gluconeogenesis in the liver, thereby lowering the amount of glucose released into the bloodstream.
Second, they improve insulin sensitivity in peripheral tissues, particularly skeletal muscle, which enhances glucose uptake and utilization.
This dual action helps to lower blood glucose levels effectively.
Additionally, biguanides may promote weight loss and have beneficial effects on lipid profiles.
They are generally well-tolerated but can cause gastrointestinal side effects such as nausea and diarrhea
Examples (-formin):
Metformin (Glucophage)
Buformin
Phenformin